Statin derivatives as therapeutic agents for castration-resistant prostate cancer.
about
Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway.p66Shc regulates migration of castration-resistant prostate cancer cells.Low-dose statin treatment increases prostate cancer aggressiveness.Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia.Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
P2860
Statin derivatives as therapeutic agents for castration-resistant prostate cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Statin derivatives as therapeutic agents for castration-resistant prostate cancer.
@en
type
label
Statin derivatives as therapeutic agents for castration-resistant prostate cancer.
@en
prefLabel
Statin derivatives as therapeutic agents for castration-resistant prostate cancer.
@en
P2093
P2860
P1433
P1476
Statin derivatives as therapeutic agents for castration-resistant prostate cancer
@en
P2093
C Brent Wakefield
Dannah R Miller
Hui-Ting Chen
Kuan-Chan Hsieh
M Vijaya Simha
Matthew A Ingersoll
Ming-Fong Lin
October Martinez
Surinder K Batra
P2860
P304
P356
10.1016/J.CANLET.2016.09.008
P407
P50
P577
2016-09-26T00:00:00Z